Agilent Technologies (NYSE:A) Updates FY 2026 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 6.000-6.100 for the period, compared to the consensus earnings per share estimate of 5.970. The company issued revenue guidance of $7.4 billion-$7.5 billion, compared to the consensus revenue estimate of $7.4 billion. Agilent Technologies also updated its Q3 2026 guidance to 1.480-1.500 EPS.

Agilent Technologies Trading Up 0.6%

NYSE:A opened at $115.82 on Thursday. Agilent Technologies has a one year low of $108.35 and a one year high of $160.27. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The firm has a market cap of $32.73 billion, a P/E ratio of 25.57, a P/E/G ratio of 2.42 and a beta of 1.22. The firm has a 50-day simple moving average of $114.99 and a 200-day simple moving average of $128.79.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business had revenue of $1.84 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same quarter in the previous year, the business posted $1.31 EPS. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities analysts anticipate that Agilent Technologies will post 5.95 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be paid a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s payout ratio is 22.52%.

Analysts Set New Price Targets

Several research analysts recently commented on A shares. Wells Fargo & Company reduced their price objective on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research note on Thursday, February 26th. Robert W. Baird boosted their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research note on Tuesday. Barclays reduced their price objective on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Royal Bank Of Canada started coverage on shares of Agilent Technologies in a research note on Wednesday. They set an “outperform” rating and a $153.00 price objective for the company. Finally, Wall Street Zen lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Two research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, Agilent Technologies has an average rating of “Buy” and a consensus price target of $162.40.

Key Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent beat Q2 expectations with adjusted EPS of $1.49 versus consensus around $1.41 and revenue of $1.83 billion versus the $1.80 billion forecast, showing solid execution and 10% year-over-year sales growth. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its full-year 2026 profit outlook, citing strong demand for lab tools and research/diagnostic equipment, which supports the case for higher earnings ahead. Agilent raises 2026 profit forecast on strong demand for lab tools
• Positive Sentiment: Management’s updated FY 2026 guidance of $6.00-$6.10 EPS and $7.4 billion-$7.5 billion revenue came in slightly above Wall Street expectations, reinforcing confidence in continued growth. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Neutral Sentiment: Analyst coverage remained constructive, with RBC starting coverage at Outperform and Baird lifting its price target, which adds support but is not a direct operating catalyst. Analyst coverage updates
• Negative Sentiment: Agilent’s Q3 EPS guidance of $1.48-$1.50 was only in line with, or slightly below, estimates, which may temper enthusiasm despite the stronger full-year outlook. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results

Institutional Trading of Agilent Technologies

Large investors have recently bought and sold shares of the stock. State Street Corp boosted its holdings in shares of Agilent Technologies by 1.9% in the 4th quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock valued at $1,725,611,000 after acquiring an additional 241,029 shares during the last quarter. Morgan Stanley boosted its holdings in shares of Agilent Technologies by 15.9% in the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock valued at $686,049,000 after acquiring an additional 692,202 shares during the last quarter. Invesco Ltd. boosted its holdings in shares of Agilent Technologies by 32.0% in the 4th quarter. Invesco Ltd. now owns 2,590,715 shares of the medical research company’s stock valued at $352,519,000 after acquiring an additional 627,804 shares during the last quarter. Ameriprise Financial Inc. boosted its holdings in shares of Agilent Technologies by 132.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after acquiring an additional 1,340,161 shares during the last quarter. Finally, AQR Capital Management LLC boosted its holdings in shares of Agilent Technologies by 424.1% in the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after acquiring an additional 1,652,244 shares during the last quarter.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.